| Study Title | LGG Avastin: A phase II & open-labeled & multi-center & randomized controlled trial of Vinblastine +/- Bevacizumab for the treatment of chemotherapy-naive children with unresectable or progressive low grade glioma |
|---|---|
| Protocol ID | OZM-063 (LGG Avastin) |
| Disease (Sub Disease) | Low Grade Glioma |
| Diagnosis Stage | New diagnosis Relapse/ refractory |
| Location | NSW / QLD / VIC / WA / SA / NZ |
| Sponsor | Australian and New Zealand Children's Haematology Oncology Group/ The Hospital for Sick Children |
| Collaborators | Hoffmann-La Roche |
| Links | https://clinicaltrials.gov/ct2/show/NCT02840409 |
| Trial Status | Closed to Recruitment |
| Trial Open Date | 29/05/2018 |
| Trial Close Date | 30/09/2023 |
| Sites | The Children's Hospital at Westmead / Perth Children's Hospital / Queensland Children's Hospital / Royal Children's Hospital / Women's & Children's Hospital / Starship Hospital/ |
| Study Type | Treatment |
| Phase | Phase 2 |
| Age Eligibility | 6 months to 18 years old |
| International registry ID's | NCT02840409 |